Replies to post #11544 on Lans Holdings Inc (fka LAHO)

[ApollyonZ]

Laho technology will certainly bring more giants profit$$.

Harvard

Breakthrough research shows that stem cell genes can be edited in living systems

..the findings have major implications for biotechnology research and the development of therapeutics for genetic diseases

https://news.harvard.edu/gazette/story/2019/06/breakthrough-harvard-research-shows-stem-cell-genes-can-be-edited-in-living-systems/

..Stem Cell Treatments Flourish With Little Evidence That They Work

..The Global Stem Cell manufacturing Market is expected to reach USD 16.51 Billion by 2025, from USD 10.28 Billion

Major Market competitors/players: Global Stem Cell manufacturing Market

Some of the major players operating in the stem cell manufacturing market are Thermo Fisher Scientific. Merck Group, Becton, Dickinson and Company. Holostem Advanced Therapies, JCR Pharmaceuticals, Organogenesis Inc, Osiris Therapeutics, Osiris Therapeutics, Vericel Corporation, AbbVie, American CryoStem, AM-Pharma, Anterogen.Co.,Ltd, Astellas Pharma, Bristol-Myers Squibb, Apceth Biopharma, Cellular Dynamics International, Rheacell, Takeda Pharmaceutical, Teva Pharmaceutical Industries Ltd. ViaCyte, VistaGen Therapeutics Inc, Translational Biosciences, GlaxoSmithKline plc, Daiichi Sankyo Company, Limited, among others.

The F.D.A. has taken an industry-friendly approach toward companies using unproven cell cocktails to treat people desperate for relief from aging or damaged joints.

https://www.nytimes.com/2019/05/13/health/stem-cells-fda.html

FDA wants partners with money, efficacy of treatment is proven.